Akoustis Technologies Inc buy JPMorgan Chase & Co.
Start price
14.07.26
/
50%
€0.001
Target price
14.07.27
€28.97
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 14.07.27. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time.Performance without dividends (%)
| Name | 1w |
|---|---|
| Akoustis Technologies Inc | - |
| iShares Core DAX® | -1,60 % |
| iShares Nasdaq 100 | 1,43 % |
| iShares Nikkei 225® | 1,11 % |
| iShares S&P 500 | 0,53 % |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Akoustis Technologies Inc diskutieren
Aktis Oncology (AKTS) had its price target raised by JPMorgan Chase & Co. from $30.00 to $33.00. They now have an "overweight" rating on the stock.
Ratings data for AKTS provided by MarketBeat